The stock may go down to single digits in a few months, then I am in. Reasons, no commercial units available yet, not profitable, millions of dollars in the RED. Illumina has a unit that is quite close to matching PacBio's. Inexperienced and disfunctional management. Yes, PACBIO maybe suited for a buyout from a larger more established and management savy company. There is one in SOCAL that I am watching closely. Notwithstanding, great potential but not yet.